Nucleoside reverse transcriptase inhibitor combination

This page covers all Nucleoside reverse transcriptase inhibitor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV reverse transcriptase.

Targets

HIV reverse transcriptase

Marketed (1)

• TAF/FTC · Göteborg University · Infectious Disease / Virology
  TAF/FTC is a fixed-dose combination of two nucleoside reverse transcriptase inhibitors that block HIV reverse transcriptase to prevent viral replication.